Nominate: Xconomy Awards →
May 13, 2020 · Boston
June 8, 2020 · National
September 1, 2020 · San Francisco
Matthew Scholz is the CEO of Immusoft, a (currently) Seattle based biotech startup that is commercializing technology to program the human immune system.
If Seattle is to occupy a future place of dominance in the biotech world, it must foster more of an “incubator” culture. There is a “valley of death” between the well-funded... Read more »
Sponsored · Special Report
Hyperinflation in rents is over
Sponsored · Whitepaper
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
What the most successful life sciences fundraising pitch decks all have in common
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.